Statistics

Total Visits

Views
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort study 215
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort study 77

Total Visits per Month

November 2023 December 2023 January 2024 February 2024 March 2024 April 2024 May 2024
Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort study 5 41 10 3 7 10 6

File Downloads

Views

Top Country Views

Views
United States 106
Australia 67
France 19
China 16
Ireland 15
Vietnam 10
Netherlands 9
Singapore 8
Germany 7
Finland 5

Top City Views

Views
Kaleen 40
Dublin 15
Boardman 11
Hanoi 10
Ashburn 8
Rotterdam 8
Singapore 7
Buffalo 6
Helsinki 5
Melbourne 5